+1,119.4%
NBIS vs THC
+58.9%
+1,060.5%
-58.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +7.7% | -2.3% | +10.0% | +8.1% |
| 7D | +22.2% | -2.6% | +24.8% | +22.7% |
| 30D | +29.7% | -1.2% | +30.9% | +29.9% |
| 3M | +11.9% | +58.9% | -47.1% | -1.9% |
| 6M | +173.0% | +9.3% | +163.7% | +170.5% |
| YTD | +191.4% | +30.4% | +161.0% | +169.0% |
| 1Y | +280.7% | +34.6% | +246.1% | +247.6% |
| All | +1,119.4% | +58.9% | +1,060.5% | +854.7% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling